Analysis of the Performance of the Software/Hardware Product MyDiaBase+RxChecker for Assessing Treatment Regimens

Abstract

In 2008, the Action to Control Cardiovascular Risk in Diabetes trial was halted due to an unexpected number of deaths in the intensive treatment group (aiming for hemoglobin A1c levels less than 6%). Hypoglycemic episodes were thought by some to be a contributing cause, underscoring again the challenge of maintaining tight control while avoiding dangerous excursions into hypoglycemic territory. Albisser and colleagues present a set of articles in this issue of Journal of Diabetes Science and Technology that describe a clinical product developed specifically for this timeless clinical conundrum.

Keywords

managing hypoglycemia telemedicine

References

Albisser

Alejandro

Sperlich

Ricordi

. Closing the circle of care with new firmware for diabetes: MyDiaBase+RxChecker. J Diabetes Sci Technol. 2009;3 (3): 613–8.

Albisser

Alejandro

Sperlich

Ricordi

. Prescription-checking device promises to resolve intractable hypoglycemia. J Diabetes Sci Technol. 2009;3 (3): 524–32.

U.S. Department of Health and Human Services: National Heart, Lung, and Blood Institute. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. http://www.nhlbi.nih.gov/health/prof/heart/other/accord/. Accessed March 25, 2009.

Bergman

. Minimal model: perspective from 2005. Horm Res. 2005;64 (Suppl. 3): 8–15.

Stahl

Johansson

. Short-term diabetes blood glucose prediction based on blood glucose measurements. Conf Proc IEEE Eng Med Biol Soc. 2008;2008: 291–4.